Opipramol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Tricyclic antidepressant with relatively little pronounced stimulant and antidepressant effect.

IndicationThis section has been translated automatically.

Anxiety, tension, restlessness, insomnia, depressive mood, lack of concentration, nervous exhaustion, also vegetative-functional organ complaints. Climacteric complaints.

ContraindicationThis section has been translated automatically.

Combination with MAO-inhibitor, acute delirium, narrow-angle glaucoma, intoxication with centrally attenuating drugs, severe transition disorders.

PreparationsThis section has been translated automatically.

Insidon

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer